Barclays’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-500
| Closed | -$1K | – | 4769 |
|
|
2021
Q4 | $1K | Sell |
500
-16,548
| -97% | -$33.1K | ﹤0.01% | 3207 |
|
|
2021
Q3 | $102K | Buy |
+17,048
| New | +$102K | ﹤0.01% | 3213 |
|
|
2021
Q2 | – | Sell |
-17,045
| Closed | -$42K | – | 4088 |
|
|
2021
Q1 | $42K | Buy |
+17,045
| New | +$42K | ﹤0.01% | 3553 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | – | – | 3674 |
|
|
2019
Q4 | $0 | Sell |
1
-4
| -80% | – | ﹤0.01% | 3898 |
|
|
2019
Q3 | $0 | Sell |
5
-36,373
| -100% | – | ﹤0.01% | 4148 |
|
|
2019
Q2 | $35K | Buy |
36,378
+28,006
| +335% | +$26.9K | ﹤0.01% | 3895 |
|
|
2019
Q1 | $12K | Buy |
8,372
+5,186
| +163% | +$7.43K | ﹤0.01% | 3986 |
|
|
2018
Q4 | $3K | Sell |
3,186
-16,718
| -84% | -$15.7K | ﹤0.01% | 3833 |
|
|
2018
Q3 | $122K | Buy |
19,904
+13,390
| +206% | +$82.1K | ﹤0.01% | 3305 |
|
|
2018
Q2 | $70K | Sell |
6,514
-1,141
| -15% | -$12.3K | ﹤0.01% | 3196 |
|
|
2018
Q1 | $82K | Buy |
7,655
+4,256
| +125% | +$45.6K | ﹤0.01% | 3260 |
|
|
2017
Q4 | $24K | Buy |
3,399
+2,920
| +610% | +$20.6K | ﹤0.01% | 3643 |
|
|
2017
Q3 | $4K | Buy |
479
+307
| +178% | +$2.56K | ﹤0.01% | 3695 |
|
|
2017
Q2 | $1K | Sell |
172
-223
| -56% | -$1.3K | ﹤0.01% | 3747 |
|
|
2017
Q1 | $3K | Sell |
395
-3,393
| -90% | -$25.8K | ﹤0.01% | 3704 |
|
|
2016
Q4 | $33K | Buy |
+3,788
| New | +$33K | ﹤0.01% | 2951 |
|